Created at Source Raw Value Validated value
June 25, 2024, noon usa

* contraindication to arb or acei, including severe aortic stenosis and angioedema * patients who are currently on active treatment with arb/acei * known bilateral renal artery stenosis * systolic bp ≤90 mmhg * egfr\<30 ml/min, if not receiving dialysis treatment * k\>5.5 mmol/l on screening laboratory testing * recent history of dizziness, vertigo, related to hypotension or orthostatic hypotension, that can lead to contraindication to acei/arbs * acute respiratory distress syndrome requiring invasive ventilation

* contraindication to arb or acei, including severe aortic stenosis and angioedema * patients who are currently on active treatment with arb/acei * known bilateral renal artery stenosis * systolic bp ≤90 mmhg * egfr\<30 ml/min, if not receiving dialysis treatment * k\>5.5 mmol/l on screening laboratory testing * recent history of dizziness, vertigo, related to hypotension or orthostatic hypotension, that can lead to contraindication to acei/arbs * acute respiratory distress syndrome requiring invasive ventilation

Sept. 29, 2022, 6 a.m. usa

contraindication to arb or acei, including severe aortic stenosis and angioedema patients who are currently on active treatment with arb/acei known bilateral renal artery stenosis systolic bp ≤90 mmhg egfr<30 ml/min, if not receiving dialysis treatment k>5.5 mmol/l on screening laboratory testing recent history of dizziness, vertigo, related to hypotension or orthostatic hypotension, that can lead to contraindication to acei/arbs acute respiratory distress syndrome requiring invasive ventilation

contraindication to arb or acei, including severe aortic stenosis and angioedema patients who are currently on active treatment with arb/acei known bilateral renal artery stenosis systolic bp ≤90 mmhg egfr<30 ml/min, if not receiving dialysis treatment k>5.5 mmol/l on screening laboratory testing recent history of dizziness, vertigo, related to hypotension or orthostatic hypotension, that can lead to contraindication to acei/arbs acute respiratory distress syndrome requiring invasive ventilation

June 16, 2021, 12:32 a.m. usa

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min, if not receiving dialysis treatment - k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - acute respiratory distress syndrome requiring invasive ventilation

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min, if not receiving dialysis treatment - k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - acute respiratory distress syndrome requiring invasive ventilation

Feb. 17, 2021, 12:31 a.m. usa

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min, not on dialysis, or k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - lvef ≤ 40% - acute respiratory distress syndrome requiring invasive ventilation

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min, not on dialysis, or k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - lvef ≤ 40% - acute respiratory distress syndrome requiring invasive ventilation

Oct. 26, 2020, 11:31 p.m. usa

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min or k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - lvef ≤ 40% - acute respiratory distress syndrome requiring invasive ventilation - immunosuppression or immunocompromised conditions other than covid-19.

- contraindication to arb or acei, including severe aortic stenosis and angioedema - patients who are currently on active treatment with arb/acei - known bilateral renal artery stenosis - systolic bp ≤90 mmhg - egfr<30 ml/min or k>5.5 mmol/l on screening laboratory testing - recent history of dizziness, vertigo, or orthostatic hypotension - lvef ≤ 40% - acute respiratory distress syndrome requiring invasive ventilation - immunosuppression or immunocompromised conditions other than covid-19.